Mustang Bio Inc has a consensus price target of $16.25, established from looking at the 11 latest analyst ratings. The last 3 analyst ratings were released from Cantor Fitzgerald, HC Wainwright & Co., and BTIG on August 24, 2023, August 16, 2023, and August 15, 2023. With an average price target of $19.67 between Cantor Fitzgerald, HC Wainwright & Co., and BTIG, there's an implied 5366.00% upside for Mustang Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
08/24/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 4902.78% | Cantor Fitzgerald | Kristen Kluska | → $18 | Reiterates | Overweight → Overweight | Get Alert |
08/16/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 6848.3% | HC Wainwright & Co. | Joseph Pantginis | → $25 | Reiterates | Buy → Buy | Get Alert |
08/15/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 4346.91% | BTIG | Justin Zelin | $20 → $16 | Maintains | Buy | Get Alert |
08/15/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 6848.3% | HC Wainwright & Co. | Joseph Pantginis | → $25 | Reiterates | Buy → Buy | Get Alert |
06/16/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 5458.64% | BTIG | Justin Zelin | $4 → $20 | Maintains | Buy | Get Alert |
06/16/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 6848.3% | HC Wainwright & Co. | Joseph Pantginis | → $25 | Reiterates | Buy → Buy | Get Alert |
05/15/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 1845.53% | HC Wainwright & Co. | Joseph Pantginis | → $7 | Reiterates | Buy → Buy | Get Alert |
03/30/2023 | MBIO | Buy Now | Mustang Bio | $0.36 | 1845.53% | HC Wainwright & Co. | Joseph Pantginis | → $105 | Reiterates | → Buy | Get Alert |
11/16/2022 | MBIO | Buy Now | Mustang Bio | $0.36 | 1011.73% | BTIG | Justin Zelin | $120 → $60 | Maintains | Buy | Get Alert |
01/24/2022 | MBIO | Buy Now | Mustang Bio | $0.36 | 1567.59% | B. Riley Securities | Mayank Mamtani | $195 → $90 | Maintains | Buy | Get Alert |
05/18/2021 | MBIO | Buy Now | Mustang Bio | $0.36 | 2957.25% | BTIG | Justin Zelin | — | Initiates | → Buy | Get Alert |
The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by Cantor Fitzgerald on August 24, 2023. The analyst firm set a price target for $18.00 expecting MBIO to rise to within 12 months (a possible 4902.78% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Mustang Bio (NASDAQ: MBIO) was provided by Cantor Fitzgerald, and Mustang Bio reiterated their overweight rating.
There is no last upgrade for Mustang Bio.
There is no last downgrade for Mustang Bio.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mustang Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mustang Bio was filed on August 24, 2023 so you should expect the next rating to be made available sometime around August 24, 2024.
While ratings are subjective and will change, the latest Mustang Bio (MBIO) rating was a reiterated with a price target of $0.00 to $18.00. The current price Mustang Bio (MBIO) is trading at is $0.36, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.